ClinicalTrials.govpublic full text
A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.
indolent b-cell nhl, indolent b-cell nhl, bendamustine, rituximab, progression-free survival, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913415
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.